BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10616934)

  • 1. The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis.
    de Lima MS; Hotoph M; Wessely S
    Psychol Med; 1999 Nov; 29(6):1273-89. PubMed ID: 10616934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs versus placebo for dysthymia.
    Lima MS; Moncrieff J
    Cochrane Database Syst Rev; 2000; (4):CD001130. PubMed ID: 11034701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of drugs versus placebo for the treatment of dysthymia.
    Lima MS; Moncrieff J
    Cochrane Database Syst Rev; 2000; (2):CD001130. PubMed ID: 10796749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
    De Lima MS; Hotopf M
    Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.
    Montgomery SA
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S9-15; discussion S16-7. PubMed ID: 12685917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
    Boyer P; Lecrubier Y; Stalla-Bourdillon A; Fleurot O
    Neuropsychobiology; 1999; 39(1):25-32. PubMed ID: 9892856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
    Haykal RF; Akiskal HS
    J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta-analysis.
    Zangani C; Giordano B; Stein HC; Bonora S; D'Agostino A; Ostinelli EG
    Hum Psychopharmacol; 2021 Nov; 36(6):e2801. PubMed ID: 34727399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pharmacotherapy algorithm for the treatment of dysthymia in Japan.
    Kitamura H; Yokoyama T; Someya T
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S49-53. PubMed ID: 10560899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.
    Levkovitz Y; Tedeschini E; Papakostas GI
    J Clin Psychiatry; 2011 Apr; 72(4):509-14. PubMed ID: 21527126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of active drugs for the treatment of dysthymia.
    Silva de Lima M; Hotopf M
    Cochrane Database Syst Rev; 2003; 2003(3):CD004047. PubMed ID: 12918001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas.
    Brunello N; Akiskal H; Boyer P; Gessa GL; Howland RH; Langer SZ; Mendlewicz J; Paes de Souza M; Placidi GF; Racagni G; Wessely S
    J Affect Disord; 1999; 52(1-3):275-90. PubMed ID: 10357046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the pharmacotherapeutic strategies for the treatment of dysthymic disorder: a systematic review.
    Quagliato LA; Primavera D; Fornaro M; Preti A; Carta MG; Nardi AE
    Expert Opin Pharmacother; 2023; 24(18):2035-2040. PubMed ID: 37787056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant efficacy in the treatment of dysthymia.
    Invernizzi G; Mauri MC; Waintraub L
    Eur Neuropsychopharmacol; 1997 Oct; 7 Suppl 3():S329-36. PubMed ID: 9405959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants for pain management in rheumatoid arthritis.
    Richards BL; Whittle SL; Buchbinder R
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008920. PubMed ID: 22071859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geriatric dysthymia.
    Kocsis JH
    J Clin Psychiatry; 1998; 59 Suppl 10():13-5. PubMed ID: 9720477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of double depression: A meta-analysis.
    May DG; Shaffer VN; Yoon KL
    Psychiatry Res; 2020 Sep; 291():113262. PubMed ID: 32763535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.